DaVitaBSP:DVAI34 +2.39%75 FCF Margin % is 6.41% as of Mar. 2026, which is 41% below its 10-year median of 10.89. GuruFocus rates BSP:DVAI34 with a GF Score™ of 75/100 and a GF Value™ of R$900.89 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 667 Healthcare Providers & Services companies, DaVita ranks better than 75.41% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. DaVita's Free Cash Flow for the
three
months ended in Mar. 2026 was R$1,144 Mil. DaVita's Revenue for the
three
months ended in Mar. 2026 was R$17,862 Mil. Therefore, DaVita's FCF Margin % for the quarter that ended in Mar. 2026 was 6.41%.
The historical rank and industry rank for DaVita's FCF Margin % or its related term are showing as below:
BSP:DVAI34'
s FCF Margin % Range Over the Past 10 Years
Min: 6.88 Med: 10.89 Max: 12.28
Current: 10.78
During the past 13 years, the highest FCF Margin % of DaVita was 12.28%. The lowest was 6.88%. And the median was 10.89%.
BSP:DVAI34's FCF Margin % is ranked better than 75.41% of 667
companies
in the Healthcare Providers & Services industry
Industry Median: 3.02
vs BSP:DVAI34: 10.78
DaVita FCF Margin % Related Terms
DaVita FCF Margin % Historical Data
* Premium members only.
The historical data trend for DaVita's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BSP:DVAI34 vs THC, EHC, ENSG: FCF Margin % Comparison
For the Medical Care Facilities subindustry, DaVita's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DaVita FCF Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, DaVita's FCF Margin % distribution charts can be found below:
* The bar in red indicates where DaVita's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DaVita (BSP:DVAI34) has a FCF Margin % of 6.41% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on DaVita and its competitors. This is 41% below median its historical median of 10.89. Over the past decade, DaVita's FCF Margin % has ranged from 6.88 to 12.28. According to the industry distribution chart, DaVita ranks #164 out of 667 companies in the Healthcare Providers & Services industry, placing it in the top 24.6%.
Is DaVita's FCF Margin % too high?
DaVita's current FCF Margin % of 6.41% is 41% below median its 10-year median of 10.89. Over the past 10 years, this metric has ranged from a low of 6.88 to a high of 12.28. The Healthcare Providers & Services industry median FCF Margin % is 3.02. DaVita's value of 6.41% is 112.3% above this industry median. Based on the distribution chart, DaVita ranks #164 out of 667 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, DaVita has a GF Score™ of 75/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does DaVita's FCF Margin % compare to THC and EHC?
According to the Healthcare Providers & Services industry distribution chart, DaVita ranks #164 out of 667 companies for FCF Margin %. This places DaVita in the top 25% of its industry — outperforming the majority of peers. The industry median FCF Margin % is 3.02. DaVita's value of 6.41% is 112.3% above this benchmark. Historically, DaVita's own FCF Margin % has ranged from 6.88 to 12.28 over the past decade. While the company's 10-year median is 10.89 vs. the industry median of 3.02, DaVita has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Healthcare Providers & Services company?
The median FCF Margin % among Healthcare Providers & Services companies is 3.02, based on 667 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. DaVita's current FCF Margin % of 6.41% is 112.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on DaVita and its competitors. For the Healthcare Providers & Services industry, the median FCF Margin % is 3.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DaVita's current FCF Margin % is 6.41%, which is 41% below median its own 10-year median of 10.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DaVita stock overvalued right now?
Based on GuruFocus' analysis, DaVita (BSP:DVAI34) is currently considered Modestly Overvalued. The stock's GF Value™ is R$900.89, compared to a current price of R$1,151.37 — trading 27.8% above its estimated fair value. The current FCF Margin % is 6.41%, which is 41% below median its 10-year median of 10.89 and 112.3% above the Healthcare Providers & Services industry median of 3.02. DaVita's overall GF Score™ is 75/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For DaVita (BSP:DVAI34), the current FCF Margin % is 6.41% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DaVita (BSP:DVAI34) Overvalued in 2026?
Based on GuruFocus' analysis, DaVita stock appears to be overvalued.
The current stock price of R$1,151.37 is trading 27.8% above its estimated GF Value™ of R$900.89.
GuruFocus considers DaVita to be Modestly Overvalued.
Key valuation signals for BSP:DVAI34:
FCF Margin %: 6.41% (41% below median its 10-year median of 10.89)
GF Value™: R$900.89 vs. price of R$1,151.37 (27.8% above fair value)
Industry Position: 112.3% above the Healthcare Providers & Services median (#164 of 667)
No single metric tells the full story. See the BSP:DVAI34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DaVita is one of the largest providers of dialysis services in the United States, boasting a market share of about 35%. The firm operates over 3,200 facilities worldwide, mostly in the US, and treats about 300,000 patients annually. Government payers dominate US dialysis reimbursement. DaVita receives about two-thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.
75GF Score
Get the complete analysis for BSP:DVAI34
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:DVAI34 has been successfully added to your 
